For Adults · Compounded Peptide

ARA-290

A peptide engineered from erythropoietin.

An 11-amino-acid peptide (also called cibinetide) designed from erythropoietin, studied in small human trials in small-fiber neuropathy. Prescribed online after a licensed provider reviews your online visit, compounded by U.S. 503A pharmacies, and shipped discreetly to every state except Alabama, Arizona, Arkansas, California, Hawaii, Kentucky, Maryland, Massachusetts, Minnesota, Mississippi, Nebraska, North Carolina, Ohio, Oregon, South Carolina, South Dakota, Tennessee, Virginia and West Virginia.

$299

Supply

One payment for a 3-month supply.

Start your online visit →

A few private questions, then a licensed provider reviews your answers.

100% Online 503A Compounded Licensed Providers Discreet Shipping
ForbiddenRx ARA-290 vial
At a glance
Form
Injection
Cadence
Set by your provider
Class
Erythropoietin-derived peptide
Guided by
Provider review
Helps with
Immune category
For
Adults 18+
The basics

What is ARA-290?

The essentials

Erythropoietin-derived peptide

FormInjection
Supply1 or 3 months
VisitOnline
  • Dosing set by your prescriber
  • Provider-reviewed, not available OTC
  • Discreet, unmarked shipping to every state except Alabama, Arizona, Arkansas, California, Hawaii, Kentucky, Maryland, Massachusetts, Minnesota, Mississippi, Nebraska, North Carolina, Ohio, Oregon, South Carolina, South Dakota, Tennessee, Virginia and West Virginia
Start your online visit →

ARA-290, also known as cibinetide, is an 11-amino-acid peptide modelled on one part of erythropoietin (EPO), the hormone that drives red blood cell production. It was designed to act on what researchers call the innate repair receptor, which is linked to tissue protection and inflammation, without stimulating red blood cell production.

The human evidence is small and early. ARA-290 has been studied in small randomised pilot trials in people with small-fiber neuropathy, mostly linked to sarcoidosis, and in one small study in type 2 diabetes with neuropathic symptoms. It has not been shown to treat any condition in large trials, and it is not an FDA-approved medication.

This is a compounded preparation, not an FDA-approved medication, and compounded drugs are not reviewed by the FDA for safety or effectiveness. Individual results are not guaranteed. It is prescribed only where a licensed provider determines it is appropriate after reviewing your health history.

Why people ask about it

Why does ARA-290 come up?

ARA-290 comes up because of small clinical studies in small-fiber neuropathy, where it was associated with changes in symptoms and in corneal nerve fibers. Those trials were small and short, and they do not establish a benefit for any other use.

✔A provider decides, not a quiz

Every ARA-290 prescription here follows a review by a licensed provider of your health history, current medications and goals. If it isn't appropriate for you, it isn't prescribed.

✔Compounded, not a research chemical

Your vial is compounded by a licensed U.S. 503A pharmacy and dispensed against a prescription written in your name, not sold as a "research only" product with no oversight.

Know the difference

Prescribed ARA-290 vs. supplements and grey-market vials: what's the difference?

The short answer: unregulated supplements make claims nobody checks, "research only" vials sold online carry no prescription, no pharmacy and no accountability, and a prescribed ARA-290 is compounded by a licensed 503A pharmacy against a provider's order written for you.

 Oral supplement"Research only" vialPrescribed ARA-290 (Rx)
What it isAn unregulated oral productA vial sold without a prescriptionCompounded ARA-290 dispensed on a provider's order
Licensed provider reviews youNoNoYes, before anything is dispensed
Compounded by a licensed pharmacyNoNoYes, U.S. 503A
Your name on the vialNoNoYes
Dose set by a prescriberNoNoYes

The simplest test of any peptide seller: is your name on the vial? A "research only" label means no prescriber reviewed you, no licensed pharmacy compounded it, and nobody is accountable for what is actually inside.

How it works

How does getting ARA-290 work?

Three steps: answer a short set of medical questions, a licensed provider reviews them, and if they prescribe, a 503A pharmacy compounds and ships it.

I

Answer a few questions

A short private medical questionnaire about your history, current medications and what you are hoping to address. It takes a couple of minutes.

II

A provider reviews your answers

A provider licensed in your state reviews your answers online. No appointment, no waiting room. They decide whether ARA-290 is appropriate.

III

Compounded & shipped

If they prescribe, a licensed U.S. 503A pharmacy compounds your vial and ships it discreetly, with your name on the label.

Who it's for

Who is ARA-290 for?

It's for adults who want ARA-290 prescribed and compounded properly rather than bought from a grey market. Whether it is appropriate for you is a decision for the provider who reviews your visit.

✔Interested in the immune category

You have read about ARA-290 and want it prescribed rather than bought from an unregulated seller.

✔You want a real prescription

Reviewed by a licensed provider, compounded by a 503A pharmacy, dispensed with your name on the vial.

✔You want the dosing decided for you

The amount and schedule are set by your prescriber, not selected here or taken from a forum.

✔You are comfortable with an injectable

ARA-290 is compounded as a subcutaneous injection.

✕When it's not the right fit

ARA-290 has been tested only in small, short human studies, mainly in small-fiber neuropathy. It has not been shown to treat neuropathy or any other condition, and it is not a substitute for evaluation of numbness, burning or nerve pain by a clinician. It is a compounded preparation, not an FDA-approved medication, and compounded drugs are not reviewed by the FDA for safety or effectiveness. Individual results are not guaranteed. If you are pregnant or breastfeeding, have an active cancer diagnosis, or have significant kidney or liver disease, tell your provider in your answers. New or unexplained symptoms should be evaluated by a clinician rather than self-treated.

How to get it

How do I get ARA-290 online?

You answer a few questions, a licensed provider reviews your answers, and if they prescribe, your medication is compounded and shipped to your door. No insurance required, no in-person appointment, no waiting room.

A few questions

Answer a short set of private medical questions. Add as many peptides as you like; one checkout, and a provider reviews each.

Online provider review

A provider licensed in your state reviews your answers online. Approval is never guaranteed.

Discreet delivery

If prescribed, your vial is compounded by a 503A pharmacy and ships in plain, unmarked packaging to every state except Alabama, Arizona, Arkansas, California, Hawaii, Kentucky, Maryland, Massachusetts, Minnesota, Mississippi, Nebraska, North Carolina, Ohio, Oregon, South Carolina, South Dakota, Tennessee, Virginia and West Virginia.

Your price is shown before you pay. No insurance needed.

Using it & safety

How is it taken, and is it safe?

ARA-290 is compounded as injection. The amount and the schedule are set by the provider who reviews your visit. We deliberately do not publish a dosing regimen here, because that is a clinical decision about you, not a product specification.

Forms & how it's taken

Injection
Compounded as injection.
Supplied as
Strength set by your prescriber.
Dose & schedule
Set by your prescriber. Follow the directions on your label.
Supply
1-month or 3-month. Three months costs less per month.
InjectionProvider-set

Safety & side effects

⚠ Early human evidence only

ARA-290 has been tested only in small, short human studies, mainly in small-fiber neuropathy. It has not been shown to treat neuropathy or any other condition, and it is not a substitute for evaluation of numbness, burning or nerve pain by a clinician. It is a compounded preparation, not an FDA-approved medication, and compounded drugs are not reviewed by the FDA for safety or effectiveness. Individual results are not guaranteed.

Reported effects are most often related to the injection itself. They can include:

  • Redness, soreness or itching at the injection site
  • Headache
  • Fatigue
  • Nausea

Tell your provider about every condition and medication before starting, including pregnancy or breastfeeding. Stop and seek care for signs of an allergic reaction: rash, swelling of the face or throat, or difficulty breathing. For emergencies call 911.

Compare your options

Which immune-support peptide fits you?

A side-by-side look at the immune support options available through ForbiddenRx. Which one is appropriate for you is decided by the provider who reviews your visit.

TreatmentWhat it isFocusFormForRx required
ARA-290
This page
Erythropoietin-derived peptideImmune categoryInjectionAdults 18+Yes
LL-37Cathelicidin peptideImmune categoryInjectionAdults 18+Yes
Thymosin Alpha-128-amino-acid peptideImmune categoryInjectionAdults 18+Yes
Questions, answered

ARA-290 FAQ

What is ARA-290?

ARA-290 (cibinetide) is an 11-amino-acid peptide designed from erythropoietin to act on the innate repair receptor without stimulating red blood cell production.

Is it the same as EPO?

No. It is modelled on one part of erythropoietin and was designed not to raise red blood cell counts. It is not EPO and does not act the same way.

Has it been studied in people?

Only in small, early trials, mostly in people with small-fiber neuropathy linked to sarcoidosis, plus one small study in type 2 diabetes. There are no large trials, and no benefit has been established.

Is it FDA-approved?

No. It is a compounded preparation, not an FDA-approved medication, and compounded drugs are not reviewed by the FDA for safety or effectiveness. Individual results are not guaranteed.

Do I have to book an appointment?

No. You complete the questionnaire online and a licensed provider reviews it. There is no scheduling step and no waiting room.

Can I order more than one peptide?

Yes. Add each one to your cart and check out once. A provider reviews every treatment in your order.

Credibility you can verify

Care held to a higher standard

Licensed Providers

Physicians, NPs & PAs licensed in your state

503A Pharmacies

U.S.-based compounding partners

Most U.S. States

We confirm your state during intake

Explore more

Also in peptides

Start with a real prescription

If you are going to take ARA-290, take one a licensed provider prescribed and a 503A pharmacy compounded with your name on it. Answer a few questions and a licensed provider reviews them.

Start your online visit →

  • Discreet, unmarked packaging
  • Refills so you never miss a dose
  • Labs guiding every adjustment
  • Licensed providers in every state except Alabama, Arizona, Arkansas, California, Hawaii, Kentucky, Maryland, Massachusetts, Minnesota, Mississippi, Nebraska, North Carolina, Ohio, Oregon, South Carolina, South Dakota, Tennessee, Virginia and West Virginia
Sources

Sources & references

Written by ForbiddenRx and checked against FDA prescribing information and published sources · Updated November 2026. It is general information, not a review of your own health; your provider decides what is right for you. It is provided for general educational purposes and is not a substitute for professional medical advice, diagnosis, or treatment. Always talk with a licensed provider about your individual health.

  1. Heij L et al. Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study. Molecular Medicine.
  2. Culver DA et al. Cibinetide improves corneal nerve fiber abundance in patients with sarcoidosis-associated small nerve fiber loss and neuropathic pain. Investigative Ophthalmology & Visual Science.
  3. Brines M et al. ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes. Molecular Medicine.
  4. U.S. Food & Drug Administration. Human Drug Compounding Laws (Section 503A), the regulatory basis for how this preparation is dispensed.
For further reading

Clinical references

This page is educational and is not medical advice.